Definium Therapeutics (DFTX) Stock Price
Definium Therapeutics Price
Analysts set a median price target of 66.00 USD, implying 91.9% above the current price. Of 24 analysts, 23 rate the stock a buy — an overall Buy consensus.
Definium Therapeutics stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Definium Therapeutics business model & stock analysis
Frequently asked questions about Definium Therapeutics
Analysts currently set an average price target of 61.27 USD for the Definium Therapeutics stock (median: 66.00 USD), implying +78.2 % versus the latest price. The consensus is based on 24 analyst ratings.
24 analysts currently rate the Definium Therapeutics stock: 23 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Definium Therapeutics share trades at 30.74 EUR (34.39 USD).
The Definium Therapeutics share (DFTX) is listed on 5 stock exchanges, including: NASDAQ (MNMD), Frankfurt (MMQ.F), München (MMQ.MU), Düsseldorf (MMQ.DU).
The revenue cannot currently be calculated for Definium Therapeutics.
The expected profit of Definium Therapeutics is -284.60 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Definium Therapeutics is currently -10.79. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Definium Therapeutics stock.
The P/S cannot be calculated for Definium Therapeutics currently.
The Eulerpool Quality Score for Definium Therapeutics is 4/10.
The ISIN of Definium Therapeutics is CA24477V1058. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Definium Therapeutics is A3DR6E. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Definium Therapeutics is DFTX. The ticker symbol is used to trade Definium Therapeutics shares on the stock exchange.
Definium Therapeutics stock
Definium Therapeutics Peer Group
Definium Therapeutics Ticker
All fundamentals and in-depth analysis of Definium Therapeutics
Our stock analysis for Definium Therapeutics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Definium Therapeutics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.